approval
saveGLATOPA (GLATIRAMER ACETATE) — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026 · 234d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026 · 234d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 235d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 235d ago
- approvalGLATIRAMER ACETATE — FDA approvalDec 31, 2025 · 277d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025 · 576d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024 · 929d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024 · 929d ago
same company · ±60 days · 4
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025
- approvalMETHYLPREDNISOLONE ACETATE: METHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025
- approvalMETHYLPREDNISOLONE ACETATE: METHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025
- approvalaflibercept biosimilar: ENZEEVU (AFLIBERCEPT-ABZV) — FDA approvalFeb 10, 2025
comments(0)
5-min edit window · permanent after that